Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any primary ciliary dyskinesia in which the cause of the disease is a mutation in the DNAJB13 gene.
Features include always present findings: Chronic rhinitis, Bronchiectasis, Male infertility, and Decreased nasal nitric oxide and others; and common findings: Recurrent bronchitis and Neonatal respiratory distress. 10 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Lungs and breathing | 5 | Absent central microtubular pair morphology of respiratory motile cilia, Bronchiectasis, Reduced respiratory ciliary beating frequency |
DNAJB13 encodes DnaJ heat shock protein family (Hsp40) member B13 (316 aa). Functions as part of axonemal radial spoke complexes that play an important part in the motility of sperm and cilia Highest expression in Testis (7.8 TPM) and Fallopian Tube (3.2 TPM).
Primary ciliary dyskinesia 34 has been associated with mutations in the DNAJB13 gene on chromosome 11.
DNAJB13 is classified as a druggable target with score 0.0.
Genetic testing for DNAJB13 is available. Testing is considered supportive for diagnosis.
Biomarker and diagnostic research for primary ciliary dyskinesia 34 has been reported in the published literature.
Phenotype severity distribution: 7 always present features, 2 common features.
No clinical trials have been registered for primary ciliary dyskinesia 34.
30 publications have been identified in PubMed for primary ciliary dyskinesia 34. Research spans Case Report / Case Series (37%), Epidemiology / Natural History (33%), and Review / Meta-Analysis (13%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 11 | 37% |
Data assembled from 6 of 12 sources · Last updated Sep 19, 2026, 2:19 AM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Hormones | 1 | Male infertility |
Pregnancy and birth | 1 | Neonatal respiratory distress |
Age of onset: newborn period.
Disease patterns and progression
10 |
33% |
Research summaries | 4 | 13% |
Laboratory research | 3 | 10% |
Testing and diagnosis research | 1 | 3% |
Clinical study results | 1 | 3% |
Hull RC (2026). [PMID: 42155496](https://pubmed.ncbi.nlm.nih.gov/42155496/). *Lancet Respir Med*. [Epidemiology / Natural History]
Piatti G (2026). [PMID: 41683661](https://pubmed.ncbi.nlm.nih.gov/41683661/). *Int J Mol Sci*. [Basic Science / Preclinical]
Živković G (2026). [PMID: 41567031](https://pubmed.ncbi.nlm.nih.gov/41567031/). *Pediatr Dev Pathol*. [Case Report / Case Series]
Choumad S (2026). [PMID: 41332971](https://pubmed.ncbi.nlm.nih.gov/41332971/). *Radiol Case Rep*. [Case Report / Case Series]
Kumar M (2026). [PMID: 42112810](https://pubmed.ncbi.nlm.nih.gov/42112810/). *Pediatr Pulmonol*. [Epidemiology / Natural History]
Ma R (2026). [PMID: 42216596](https://pubmed.ncbi.nlm.nih.gov/42216596/). *Br J Hosp Med (Lond)*. [Case Report / Case Series]
Demirtas İ (2025). [PMID: 41316455](https://pubmed.ncbi.nlm.nih.gov/41316455/). *J Med Case Rep*. [Case Report / Case Series]
Hijikata M (2025). [PMID: 39805680](https://pubmed.ncbi.nlm.nih.gov/39805680/). *J Med Genet*. [Diagnostic / Biomarker]
Legebeke J (2025). [PMID: 39536325](https://pubmed.ncbi.nlm.nih.gov/39536325/). *Hum Mol Genet*. [Basic Science / Preclinical]
Mar Conde MD (2025). [PMID: 39034274](https://pubmed.ncbi.nlm.nih.gov/39034274/). *Int J Surg Pathol*. [Case Report / Case Series]